2/26/2026China Accelerates Dementia Research to Challenge U.S. Leadership

2/26/2026Pfizer Updates Pneumococcal Vaccine Trial in China, Implications for I...

2/26/2026Jiuyuan Files for Approval of Wegovy Biosimilar in China

2/26/2026China Pharmaceutical Market Projected to Reach US$573B by 2033

2/26/2026U.S. ITC to Probe China's Trade Status and Biotech Practices

2/26/2026China Expands Mutual Recognition of Medical Tests to Streamline Care a...

2/26/2026China's Biopharma Boom Attracts Global Investment Amid Innovation Surg...

2/26/2026BMS-Partnered Bispecific ADC Achieves Dual Survival Milestones in Chin...

2/26/2026China's Healthcare Reform Playbook: Boosting Births and Opening the Do...

2/25/2026Global Pharma Giants Rush to License Chinese Weight-Loss Drugs, Eye Ob...

2/25/2026Henlius Expands Global Footprint with Exclusive Abbott Licensing Deal ...

2/25/2026Slate Medicines Launches With $130M to Advance China-Licensed PACAP Mi...

2/25/2026Kelun-Biotech's sac-TMT OS Data Selected as Late-Breaker at ELCC 2026

2/25/2026CStone Secures UK Approval for Sugemalimab in Stage III NSCLC

2/25/2026China Schedules Antitrust Hearing in Abuse‑of‑Dominance Case Tied to...

2/24/2026Harbour BioMed Strikes $1.1B-Plus Ex-China Deal for Anti-CTLA-4 Antibo...

2/24/2026Huadong Launches Head-to-Head Phase III Trial for Dual GLP-1/GIP Agoni...

2/24/2026CDE Issues Guidelines on Benefit-Risk Assessment Using Multi-Regional ...

2/24/2026Biokin's Iza-Bren Achieves Second Phase III Survival Success in China ...

2/24/2026After 230% Deal Size Explosion, China Is No Longer the 'Bargain Baseme...

2/21/2026Hansoh Pharma's Ameile Wins EU Approval for EGFR-Mutant Lung Cancer

2/21/2026Leo Pharma Eyes China Comeback After Decade-Long Launch Drought

2/20/2026China Biotech Kicks Off 2026 with $863 Million in January Raises

2/16/2026China's Innovation in Translational Medicine: Rethinking Early-stage C...

2/16/2026Long-Acting Obesity Drugs Drive Record January Licensing Boom for Chin...

2/14/2026Recordati to Withdraw from China After Rare Disease Portfolio Underper...

2/13/2026Pentagon Reverses Decision After Briefly Listing WuXi AppTec as Chines...

2/13/2026Shenzhen Immunofoco Biotechnology files Hong Kong IPO application

2/13/2026China Biotech Dealmaking and Financing Stay Strong in January 2026 Des...

2/12/2026Today's China Crucible: What It Means for Pharma (PharmExec)

Page:1/380 Total number of articles:11397: [First][<<] [1] [2] [3] [4] [5] [>>] [End]